| Original language | English |
|---|---|
| Pages (from-to) | E1596-E1599 |
| Journal | CMAJ |
| Volume | 193 |
| Issue number | 41 |
| DOIs |
|
| Publication status | Published - Oct 18 2021 |
Bibliographical note
Funding Information:Lastly, a mechanism for adequate research funding, independent of industry, is required. Successfully established national research infrastructure is already in place with organizations such as the Canadian Childhood Cannabinoid Clinical Trials (C4T) Consortium (www.C4Trials.org), the Canadian Consortium for the Investigations of Cannabinoids and the Cannabinoid Research Initiative of Saskatchewan. These bodies are equipped to conduct highquality, multicentre pediatric medical cannabis research in Canada. If adequate funding were made available, Canada would be well positioned to contribute greatly to the evidence base supporting the safe and effective use of medical cannabis for children whose treatment needs are otherwise inadequately met. Private– public partnerships can play an important part in ensuring research funding. For instance, a partnership between the Jim Pattison Children’s Hospital Foundation, the Children’s Hospital Foundation of Manitoba, along with Saskatchewan Health Research Foundation and Research Manitoba is being developed to provide a mechanism for licensed producers to donate nondirected funds dedicated to pediatric cannabis research. Once established, researchers will be able to apply for funding using the peerreview processes of the Saskatchewan Health Research Foundation and Research Manitoba. Intergovernmental coordination to ensure earmarking of a percentage of taxation revenues from recreational cannabis sales for research (including research on pediatric cannabis use) would also foster a better evidence base.
ASJC Scopus Subject Areas
- General Medicine
PubMed: MeSH publication types
- Journal Article